⌘K

Home/Filings/4/0001415889-23-012231

4//SEC Filing

Atadja Peter 4

Accession 0001415889-23-012231

CIK 0001130598other

View on SEC.gov Company Profile

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 5:49 PM ET

Size

5.4 KB

Accession

0001415889-23-012231

Insider Transaction Report

Form 4

Period: 2023-08-10

Onconova Therapeutics, Inc.ONTX

Director

Transactions

Award
Stock Option (right to purchase)
2023-08-10+66,468→ 66,468 total
Exercise: $1.02From: 2024-08-10Exp: 2033-08-10→ Common Stock (66,468 underlying)

Footnotes (1)

[F1]These options vest 100% on the first anniversary of the grant date.

Documents

1 file

4
form4-08142023_090853.xmlPrimary

Issuer

Onconova Therapeutics, Inc.

CIK 0001130598

Entity typeother

Related Parties

1

filerCIK 0001958563

Filing Metadata

Form type: 4
Filed: Aug 13, 8:00 PM ET
Accepted: Aug 14, 5:49 PM ET
Size: 5.4 KB

View on SEC.gov